老年髋部骨折手术中脂质体布比卡因切口浸润的随机平行组试验
本研究为单中心、前瞻性、随机、参与者和评估者盲法的平行组探索性试验,纳入76例因髋部骨折行半髋或全髋置换的老年患者,比较局部脂质体布比卡因浸润与无局部浸润。主要终点术后48小时静息痛VAS两组无差异(中位数均为0,p=0.143),但多个次要终点(如24小时静息痛、8/24/48小时活动痛、口服补救镇痛次数、睡眠质量及手术夜总睡眠时间) favoring LB。结论认为在标准化多模式镇痛路径下,LB局部浸润未改善主要终点,当前证据不支持常规临床使用。
要点
- 术后48小时静息痛VAS主要终点两组无显著差异(中位数均为0,p=0.143)。
- LB组在24小时静息痛、8/24/48小时活动痛及口服补救镇痛次数(25 vs 50 MME)上更优。
- LB组术后睡眠质量NRS更高且手术夜总睡眠时间更长,但觉醒次数相似。
核心结论
- 在标准化多模式镇痛路径下,老年髋部骨折手术局部切口浸润LB未改善预设主要终点术后48小时静息痛。
- 当前证据不支持LB常规临床使用,需进一步研究。
研究设计与样本
- 单中心、前瞻性、随机、参与者和评估者盲法、平行组探索性试验。
- 纳入76例因髋部骨折行半髋或全髋关节置换的老年患者(中位年龄77岁,49例女性)。
- 干预为局部LB浸润,对照为无局部浸润。
主要发现
- 主要终点术后48小时静息痛VAS两组无差异(中位数均为0,p=0.143;组间差异Cohen d=-0.506,95%CI -0.962至-0.048)。
- LB组术后睡眠质量NRS更高,手术夜总睡眠时间更长,觉醒次数两组相似。
- 48和72小时步行能力及术后至出院天数两组无差异。
关键数值与推荐
- 主要终点为术后48小时静息痛VAS(0-10分)。
- 预设关键次要终点包括活动痛、PCA输注液及围手术期口服和肌注补救镇痛的MME、睡眠质量NRS(0-10分)、总睡眠时间和夜间觉醒次数。
- 证据等级为治疗性I级。
临床怎么用
- 在标准化多模式镇痛路径下,不应常规添加LB局部切口浸润以改善48小时静息痛。
- LB可能对早期活动痛、补救镇痛需求和睡眠质量有短期益处,但需权衡后个体化考虑。
局限性
- 单中心探索性试验,样本量较小(76例)。
- 主要终点两组中位数均为0,可能存在地板效应。
- 随访仅至出院,未评估长期功能结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Hip fracture volumes are rising with population aging, and inadequate analgesia following hip fracture surgery has been shown to impede early mobilization and recovery. Liposomal bupivacaine (LB) may extend analgesia, but previous orthopaedic trials have yielded mixed results. We therefore tested whether adding local incisional infiltration of LB to multimodal analgesia confers clinically relevant advantages in geriatric hip fracture surgery. METHODS: This study was a single-center, prospective, randomized, participant and assessor-blinded, parallel-group exploratory trial in older adults undergoing hemiarthroplasty or total hip arthroplasty for a hip fracture. The intervention was local LB infiltration; the control was no local infiltration. The primary end point was resting pain measured on a visual analog scale (VAS, 0 to 10) at 48 hours postoperatively. Prespecified key secondary end points included early pain with activity, morphine milligram equivalents (MME) of the patient-controlled analgesia (PCA) infusion volume and of the total perioperative oral and intramuscular rescue counts, sleep quality measured on a numerical rating scale (NRS, 0 to 10), total sleep time, and nocturnal awakenings. RESULTS: A total of 76 patients (median age, 77 years; 49 female) were included in the analysis. The primary end point did not differ between the groups (median 0 for both; p = 0.143; point estimate of between-group difference: Cohen d = -0.506, 95% confidence interval: -0.962, -0.048), whereas several secondary outcomes significantly favored LB, including resting pain at 24 hours; activity pain at 8, 24, and 48 hours; and oral rescue administrations (median and interquartile range: 25 [0, 50] versus 50 [25, 100] MME). The LB group had a higher NRS sleep quality score after surgery, with a longer total sleep duration on the operative night, than the control group; the number of awakenings was similar between the groups. Ambulation at 48 and 72 hours and the number of postoperative days to discharge did not differ between the groups. CONCLUSIONS: In the context of a standardized multimodal analgesic pathway, local incisional infiltration of LB did not improve the prespecified primary end point of resting pain at 48 hours after geriatric hip fracture surgery. Overall, the current evidence does not support routine clinical use, and further investigation is warranted. LEVEL OF EVIDENCE: Therapeutic Level I. See Instructions for Authors for a complete description of levels of evidence.
引用
- Yu X, Yuan Y, Zhao S, et al. Incisional Infiltration of Liposomal Bupivacaine in Geriatric Hip Fracture Surgery: A Randomized Parallel-Group Trial. J Bone Joint Surg Am. 2026. PMID: 42302095. doi:10.2106/JBJS.25.01498
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。